ADVANCED UROTHELIAL CARCINOMA
Clinical trials for ADVANCED UROTHELIAL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new ADVANCED UROTHELIAL CARCINOMA trials appear
Sign up with your email to follow new studies for ADVANCED UROTHELIAL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug duo targets hard-to-treat bladder cancer in phase 2 trial
Disease control Recruiting nowThis study tests a new drug (trastuzumab rezetecan) alone or with an immunotherapy (adebrelimab) in people with advanced bladder cancer that has spread and shows HER2 protein. About 96 adults with HER2-positive urothelial carcinoma will receive the treatment to see if tumors shri…
Matched conditions: ADVANCED UROTHELIAL CARCINOMA
Phase: PHASE2 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated May 26, 2026 03:15 UTC
-
New pill combo shows promise in advanced cancer trial
Disease control Recruiting nowThis early-stage study tests a new daily pill, FX-909, alone or with another drug (pembrolizumab), in people with advanced solid tumors, including bladder cancer. The main goals are to check safety and find the best dose. About 120 adults will take part, with regular blood tests …
Matched conditions: ADVANCED UROTHELIAL CARCINOMA
Phase: PHASE1 • Sponsor: Flare Therapeutics Inc. • Aim: Disease control
Last updated May 26, 2026 03:09 UTC
-
New hope for bladder cancer: maintenance immunotherapy after combo treatment
Disease control Recruiting nowThis study tests whether a maintenance dose of the immunotherapy drug pembrolizumab can help keep advanced bladder cancer from progressing after an initial combination treatment. About 97 adults with untreated metastatic urothelial carcinoma will receive the combo therapy for 18 …
Matched conditions: ADVANCED UROTHELIAL CARCINOMA
Phase: PHASE2 • Sponsor: Fox Chase Cancer Center • Aim: Disease control
Last updated May 22, 2026 13:52 UTC